Anti-Doping Laboratory Qatar ( ADLQ ) has participated recently in ( The Obesity Society’s 30th Annual Scientific Meeting ) held in San Antonio, Texas, USA in the period from 20th to 24th of September, 2012. The event is considered one of the world’s largest gatherings of obesity professionals at all stages of their careers, including leading obesity scientists presenting cutting-edge research, world-renowned speakers, clinicians, educators, advocates, policymakers and practitioners.
It is an important forum for increasing knowledge, stimulating research, and promoting better treatment for those affected by this disease. Since unfortunately, the prevalence rates of obesity, and its associated diseases, such as diabetes and high blood pressure, amongst Qataris is one of the highest globally, it was only natural to have Qatar participating in such an event.
The team included Dr Nelson Orie, Aysha Bakhamis and Mashael Al Jaber. They have presented a poster which showed that young but morbidly obese and highly insulin resistant female Qataris suffer profound endothelial dysfunction even though their lipid profile and blood pressure may appear normal.
The work forms part of Aysha’s PhD project. Aysha, and Mashael are registered on the first non-resident PhD program in Qatar, under an agreement with University College London (UCL). This means their work is done entirely in Qatar, at the ADLQ labs, but is registered full-time at UCL, therefore needing to fulfill all the criteria of quality and quantity demanded of other students pursuing the same program while based in London.
Aysha Bakhamis commented that ‘the poster attracted many visitors/scientists and was a really good opportunity to meet, discuss and chat with people working in the same field with different thoughts, interests and skills.’
‘We are proud to say that this was the only presentation at the meeting from researchers in the GCC and the Arab World and is especially exciting as it’s based on work done entirely in Qatar, with the surgical/clinical samples from Qatari patients provided by Dr Mohammed Al Emadi and his team. The initiative has been developed in collaboration with Aspetar. ’ said Dr Mohammed AlSayrafi, General Manager of ADLQ, who also attended the meeting.
He added ‘ This program will serve three important purposes. First, provide academic and technical training for young Qatari scientists at post-graduate and post-doctoral stages of their careers. Second, encourage multidisciplinary collaboration between local institutions, and third, generate results that promote the understanding of the mechanisms involved in locally relevant diseases, so that we can ultimately offer treatment regimens tailored to our population.’